CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $491,000 | -1.6% | 75,000 | 0.0% | 0.01% | -50.0% |
| Q3 2020 | $499,000 | -20.2% | 75,000 | 0.0% | 0.01% | -41.2% |
| Q2 2020 | $625,000 | -18.5% | 75,000 | -25.0% | 0.02% | -46.9% |
| Q1 2020 | $767,000 | -7.7% | 100,000 | 0.0% | 0.03% | +18.5% |
| Q4 2019 | $831,000 | +12.6% | 100,000 | 0.0% | 0.03% | -6.9% |
| Q3 2019 | $738,000 | -47.4% | 100,000 | -20.0% | 0.03% | -12.1% |
| Q2 2019 | $1,403,000 | +4.4% | 125,000 | 0.0% | 0.03% | -21.4% |
| Q1 2019 | $1,344,000 | -28.8% | 125,000 | 0.0% | 0.04% | -44.0% |
| Q4 2018 | $1,888,000 | -18.4% | 125,000 | 0.0% | 0.08% | +50.0% |
| Q3 2018 | $2,313,000 | – | 125,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |